MAP4K4 and cervical cancer: Since MAP4K4 was at the upstream of SOX6-induced autophagy, its inhibitor might be more specific in inhibiting autophagy and subsequently increasing the sensitivity of cervical cancer cells to cisplatin chemotherapy.